biotechnologieunternehmen in Retschwil

Biogen entwickelt produziert und vermarktet innovative Therapien für Patienten seltenen schweren neurologischen und Autoimmun-Erkrankungen.

View contact information for the Gilead Switzerland office.

Hans Peter Hasler. Experienced Pharma-and Biotech-Executive. From 2001 on with Biogen Idec. Most recently, until mid-2009, Chief Operating Officer of Biogen Idec Inc., Cambridge/USA. Various Exec…

Amphasys provides label-free analysis of single cell characteristics such as cell size and morphology viability (vitality) ploidy or cell differentiation. / Pollen Spore(s) Seed Single Cell(s) Vi…